Pharma Journalist 7836 posts 0 comments

AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...

Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma…
Read More...

Bristol-Myers Squibb (BMS) and Calithera Biosciences expanded their collaboration to evaluate BMS’s Opdivo in combination with Calithera’s CB-839 in patients with non-small cell lung…
Read More...

NOXXON Pharma signed an agreement with the National Center for Tumor Diseases (NCT) in Heidelberg. Under the agreement NCT will conduct a trial evaluating NOXXON’s lead product…
Read More...

AMAG Pharmaceuticals announced that Helen Milton has been appointed as AMAG's Regulatory Affairs vice president. She will be responsible for regulatory activities along with company’s…
Read More...

Synlogic announced that it has entered into a definitive merger agreement with a wholly owned subsidiary of Mirna in an all-stock transaction and will continue under the Synlogic name.…
Read More...

Catalent Pharma Solutions announced that it has collaborated with Therachon AG to support preclinical and clinical development of TA-46. TA-46 is a novel protein addressing…
Read More...

Thermo Fisher Scientific and Patheon together announced that their boards of directors have approved Thermo Fisher's acquisition of Patheon at a price of $7.2 billion. Thermo Fisher…
Read More...

Upon the approval from the FDA to sell vadadustat to Fresenius Medical Care dialysis clinics in the US, Akebia Therapeutics and Vifor Pharma Group entered into an exclusive license…
Read More...